158 related articles for article (PubMed ID: 2473798)
21. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors.
Ryan DH; Chapple CW; Kossover SA; Sandberg AA; Cohen HJ
Blood; 1987 Sep; 70(3):814-21. PubMed ID: 2957002
[TBL] [Abstract][Full Text] [Related]
23. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia.
Campana D; Janossy G
Blood; 1986 Dec; 68(6):1264-71. PubMed ID: 3535926
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
25. Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow.
Foot AB; Potter MN; Ropner JE; Wallington TB; Oakhill A
J Clin Pathol; 1990 Oct; 43(10):857-9. PubMed ID: 2146287
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.
Gore S; Kastan M; Civin C
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():39-41. PubMed ID: 1697192
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
28. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
29. Antigenic phenotype of TdT-positive cells in human peripheral blood.
Bradstock KF; Kerr A; Bollum FJ
Cell Immunol; 1985 Feb; 90(2):590-8. PubMed ID: 3155660
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
31. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
32. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors.
Wolf ML; Buckley JA; Goldfarb A; Law CL; LeBien TW
J Immunol; 1991 Nov; 147(10):3324-30. PubMed ID: 1719075
[TBL] [Abstract][Full Text] [Related]
33. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
34. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
35. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
Tang YM
Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
[TBL] [Abstract][Full Text] [Related]
36. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
[TBL] [Abstract][Full Text] [Related]
37. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
Campana D; Thompson JS; Amlot P; Brown S; Janossy G
J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
[TBL] [Abstract][Full Text] [Related]
38. Lack of correlation between immunoglobulin and T cell receptor gene rearrangements and TdT expression in acute myeloid leukaemia.
Davey G; Bradstock KF; Kefford RF; Wishart Y; Kabral A; Grimsley P; Hughes WG
Leuk Res; 1990; 14(1):77-83. PubMed ID: 1689438
[TBL] [Abstract][Full Text] [Related]
39. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H
J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
